Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article from Michigan Advance referenced a study published in the November 2023 issue of The American Journal of Managed Care® (AJMC®). The study, “Medicare Advantage in Rural Areas: Implications for Hospital Sustainability,” found that Medicare Advantage penetration rose between 2008 and 2019, associated with an increase in hospital sustainability.
An article by Very Well Health referenced an article published in a 2023 supplement to AJMC, titled “Evolving Considerations for Choice of Hepatitis B Vaccine.” The overview provided considerations for the hepatitis B vaccine based on the clinical data around the vaccines and CDC recommendations.
An article from AI in Healthcare referenced a video interview published on AJMC.com, the website of AJMC. The video interview, “AI Is Changing the Landscape of Cardiovascular Care,” focused on how artificial intelligence can help both clinicians and health systems in their abilities to screen for cardiorenalmetabolic disease as well as distinguish between them.
What the Updated Telephone Consumer Protection Act Rules Mean for Health Care Messaging
April 4th 2025As new Federal Communications Commission rules take effect April 11, 2025, mPulse CEO Bob Farrell explains how health organizations can stay compliant while building patient trust through transparency and personalized engagement.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen